Wellington Management Group’s Tenaya Therapeutics TNYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-294,133
Closed -$568K 2034
2024
Q3
$568K Buy
294,133
+77,235
+36% +$218K ﹤0.01% 1803
2024
Q2
$672K Buy
216,898
+23,677
+12% +$97.8K ﹤0.01% 1747
2024
Q1
$1.01M Buy
+193,221
New +$924K ﹤0.01% 1687
2023
Q4
Sell
-188,751
Closed -$481K 1925
2023
Q3
$481K Buy
188,751
+72,726
+63% +$304K ﹤0.01% 1703
2023
Q2
$681K Buy
+116,025
New +$674K ﹤0.01% 1655

Other funds holding TNYA

Wellington Management Group's TNYA Position: Q4 2024 in Review

Wellington Management Group sold out of Tenaya Therapeutics (TNYA) in Q4 2024, closing a stake of 294,133 shares — an estimated $568K sold.

Wellington Management Group first reported a position in TNYA in Q2 2023 and held it in 5 quarters. The position peaked at $1.01M in Q1 2024. 88 funds tracked by Wall St. Rank hold TNYA as of Q4 2024.

  • Wellington Management Group reported no remaining Tenaya Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Wellington Management Group sold 294,133 Tenaya Therapeutics shares in Q4 2024, an estimated $568K.
  • Wellington Management Group first reported a position in Tenaya Therapeutics in Q2 2023 and held it in 5 quarters.
  • Wellington Management Group's Tenaya Therapeutics position peaked at $1.01M in Q1 2024.
  • 88 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q4 2024.

Based on Wellington Management Group's 13F filing for Q4 2024, filed 12 Feb 2025.